Details of the Drug

General Information of Drug (ID: DMXJ2FG)

• Drug Name: Vancomycin hydrochloride
• Synonyms: AeroVanc; Vancomycin HCL; VANCOMYCIN HYDROCHLORIDE; Vancomycin monohydrochloride; 1404-93-9; UNII-71WO621TJD; VANCOR; Vancocine hydrochloride; 71WO621TJD; Vancocin hydrochloride; Vancomycin, hydrochloride; Vancomycin hydrochloride from Streptomyces orientalis; 1404-90-6 (Parent); Vancomycin, monohydrochloride; SR-01000076194; Prestwick_816; Vancomycin hydrochloride [USP:JAN]; Cancocin hydrochloride; Vancocin hydrochloride in plastic container; Vancomycin HCl (Vancocin); CHEMBL3747636; CHEMBL1200628; LCTORFDMHNKUSG-XTTLPDOESA-N; M

Indication

Disease Entry	ICD 11	Status	REF
Staphylococcus infection	1B5Y	Phase 3	[1]

• Chemical Identifiers:
  Formula: C66H76Cl3N9O24
  Canonical SMILES: CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O.Cl
  InChI: InChI=1S/C66H75Cl2N9O24.ClH/c1-23(2)12-34(71-5)58(88)76-49-51(83)26-7-10-38(32(67)14-26)97-40-16-28-17-41(55(40)101-65-56(54(86)53(85)42(22-78)99-65)100-44-21-66(4,70)57(87)24(3)96-44)98-39-11-8-27(15-33(39)68)52(84)50-63(93)75-48(64(94)95)31-18-29(79)19-37(81)45(31)30-13-25(6-9-36(30)80)46(60(90)77-50)74-61(91)47(28)73-59(89)35(20-43(69)82)72-62(49)92;/h6-11,13-19,23-24,34-35,42,44,46-54,56-57,65,71,78-81,83-87H,12,20-22,70H2,1-5H3,(H2,69,82)(H,72,92)(H,73,89)(H,74,91)(H,75,93)(H,76,88)(H,77,90)(H,94,95);1H/t24-,34+,35-,42+,44-,46+,47+,48-,49+,50-,51+,52+,53+,54-,56+,57+,65-,66-;/m0./s1
  InChIKey: LCTORFDMHNKUSG-XTTLPDOESA-N
• Cross-matching ID:
  PubChem CID: 6420023
  CAS Number: 1404-93-9
  TTD ID: D0B5GS
• Drug ADMET Endpoint Profile (DAE)NEW: Click to Jump to the Detailed DAE Information of This Drug

References

• [1] ClinicalTrials.gov (NCT03181932) A Study of AeroVanc for the Treatment of MRSA Infection in CF Patients. U.S. National Institutes of Health.